Translate this page into:
Original Contributions
PMID: 20921682
Comparative study of ketoconazole and itraconazole in pityriasis versicolor
VK Jain, Kamal Aggarwal
Department of Skin, V.D. and Leprosy, Pt. B.D.S. PGIMS, Rohtak-124 001, India
Correspondence Address:
V K Jain
Department of Skin, V.D. and Leprosy, Pt. B.D.S. PGIMS, Rohtak-124 001
India
Correspondence Address:
V K Jain
Department of Skin, V.D. and Leprosy, Pt. B.D.S. PGIMS, Rohtak-124 001
India
| How to cite this article: Jain V K, Aggarwal K. Comparative study of ketoconazole and itraconazole in pityriasis versicolor. Indian J Dermatol Venereol Leprol 1999;65:267-266 |
Copyright: (C)1999 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
Forty patients with pityriasis versicolor were treated with either oral ketoconazole, 200mg per day for 5 days ( 20 patients) or oral itraconazole, 200mg per day for 5 days (20 patients). On global assessment after 2 weeks, 17 ( 85%) out of 20 patients treated with oral ketoconazole were cured while 3 cases had considerable residual lesions. In oral itraconazole-treated group, 19 (95%) out of 20 patients were cured and one case still had considerable residual lesions. No significant difference was observed in response rates in the two groups. Relapse occurred in 3 patients of ketoconazole group and 1 patient of itraconazole group during the follow-up period of 4 months.
Keywords: Ketoconazole, Itraconazole, Pityriasis versicolor
Fulltext Views
1,093
PDF downloads
1,056
